Brussels, 6 February 2025
The European Health and Digital Executive Agency (HaDEA) has published the EU4Health Prior Information Notice HADEA/2025/CPN/0008-PIN – Multiple sourcing Framework Contracts to speed up the development of and access to innovative medical countermeasures – Next-Generation Influenza Vaccines.
This call for tenders will aim to speed up the development of next generation influenza vaccines that could be produced in rapidly scalable manufacturing platforms (e.g. nucleic acid approaches and/or production in scalable eukaryotic or bacterial cell culture, in plants or via in vitro transcription), could support products utilising novel administration routes (e.g. nasal, oral or through microneedle patches), confer mucosal immunity, target potentially pandemic influenza A viruses or could be rapidly adapted to pandemic influenza A viruses, which are protective across influenza subtypes or across alpha-influenza viruses, and/or possess intrinsic immunogenicity without the addition of adjuvants.
Estimated budget: €147,951,410 (indicative ceiling for each of the framework contracts to be signed)
This action supports the policy priority to enhance the availability and accessibility of medical countermeasures and critical medicines, to support innovation and access regarding such products and to ultimately enhance preparedness for future health emergencies in synergy with Horizon Europe. It implements the EU4Health Programme’s general objective of improving the availability, accessibility and affordability of medicinal products and medical devices and crisis-relevant products (Article 3, point (c), of Regulation (EU) 2021/522) through the specific objectives defined in Article 4, points (b) and (c), of Regulation (EU) 2021/522.
Interested parties are invited to check theFunding and Tenders Portalfor the indicative publication of the call in April 2025.
Background
EU4Health is the fourth and largest of the EU health programmes. The EU4Health programme goes beyond an ambitious response to the COVID-19 crisis to address the resilience of European healthcare systems. The programme provides funding to national authorities, health organisations and other bodies through grants and public procurement, contributing to a healthier Europe.
Source – EU Commission – HaDEA